9th Joint Meeting ISICR-ICS Cytokines & Interferons: From the ...

Sergei Grivennikov, Ph.D.
University of California, San Diego
School of Medicine
Department of Pharmacology
Sergei Grivennikov did his PhD with Dr. Sergei Nedospasov at Engelhardt Institute for Molecular Biology in Moscow and later
on in 2006 joined Michael Karin's lab at UCSD for his postdoctoral training. He studies the role of cytokines in the tumor
microenvironment and how immune system interacts with tumors to promote or to inhibit tumorigenesis and tumor growth.
Clio P Mavragani, MD, PhD
Lecturer in Experimental/Applied Physiology
School of Medicine,
University of Athens,
Athens, Greece
Dr. Mavragani received her MD and PhD degrees, both with honors, from the National University of Athens, Greece. She also
received a Diploma Degree in Internal Medicine from Imperial College, University of London with distinction. She was trained
in Rheumatology at the Department of Pathophysiology, University of Athens (Head: Prof. HM Moutsopoulos). Following her
clinical fellowship, she joined the lab of Peggy Crow at Hospital for Special Surgery in New York as a recipient of S. Niarchos
Foundation International Exchange Fellowship. Her research focuses on the contribution of genomic retroelements in activation
of type I IFN system in systemic autoimmune disorders, including Sjogren’s syndrome and systemic lupus erythematosus, the
interactions between TNF and IFNs pathways, as well as the potential role of type I Interferons as biomarkers of response in
patients with rheumatoid arthritis receiving anti-TNF therapies.
FEBRUARY 2011 I VOLUME 18 I NO. 1 15